EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The 9p21.3 Coronary Artery Disease Risk Locus Drives Vascular Smooth Muscle Cells to an Osteochondrogenic State

Elsa Salido, Carolina de Medeiros Vieira, Jose Verdezoto Mosquera iD, Rohan Zade, Parth Parikh iD, Shraddha Suryavanshi iD, Clint L Miller iD, Valentina Lo Sardo iD

Arteriosclerosis, Thrombosis, and Vascular Biology · 2025-05 · 45 (5) · 702-721

DOI: 10.1161/atvbaha.124.322045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2025-05. Verfasst von Elsa Salido und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell and Regenerative Biology, University of Wisconsin-Madison, Madison (E.S., C.d.M.V., R.Z., P.P., S.S., V.L.S.). Hauptthemen laut MEDLINE: Muscle, Smooth, Vascular, Myocytes, Smooth Muscle, Induced Pluripotent Stem Cells, Chromosomes, Human, Pair 9. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Genome-wide association studies have identified common genetic variants at ≈300 human genomic loci linked to coronary artery disease susceptibility. Among these genomic regions, the most impactful is the 9p21.3 coronary artery disease risk locus, which spans a 60-kb gene desert and encompasses ≈80 SNPs (single nucleotide polymorphism) in high linkage disequilibrium. Despite ≈2 decades since its discovery, the role of the 9p21.3 locus in cells of the vasculature remains incompletely resolved. METHODS: We differentiated induced pluripotent stem cells (iPSCs) from risk, nonrisk donors at 9p21.3, and isogenic knockouts into vascular smooth muscle cells (VSMCs). We performed single-cell transcriptomic profiling, including coembedding and comparison with publicly available human arterial data sets. We conducted functional characterization using migration and calcification assays and confirmed our findings on iPSC–VSMCs derived from additional donors. Finally, we used overexpression of ANRIL followed by gene expression analysis. RESULTS: We demonstrated that iPSC–VSMCs harboring the 9p21.3 risk haplotype preferentially adopt an osteochondrogenic state and show remarkable similarity to fibrochondrocytes from human artery tissue. The transcriptional profile and functional assessment of migration and calcification capacity across iPSC–VSMC lines from multiple donors concordantly resemble an osteochondrogenic state. Importantly, we identified numerous transcription factors driving different VSMC state trajectories. Additionally, we prioritized LIMCH1 and CRABP1 as signature genes critical for defining the risk transcriptional program. Finally, overexpression of a short isoform of ANRIL in 9p21.3 knockout cells was sufficient to induce the osteochondrogenic transcriptional signature. CONCLUSIONS: Our study provides new insights into the mechanism of the 9p21.3 risk locus and defines its previously undescribed role in driving a disease-prone transcriptional and functional state in VSMCs concordant with an osteochondrogenic-like state. Our data suggest that the 9p21.3 risk haplotype likely promotes arterial calcification, through altered expression of ANRIL , in a cell type–specific and cell-autonomous manner, providing insight into potential risk assessment and treatment for carriers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscle, Smooth, VascularMyocytes, Smooth MuscleInduced Pluripotent Stem CellsChromosomes, Human, Pair 9Coronary Artery DiseaseVascular CalcificationHumansGenetic Predisposition to DiseaseCell MovementRNA, Long NoncodingPolymorphism, Single NucleotideCells, CulturedPhenotypeRisk FactorsCell DifferentiationHaplotypesGene Expression ProfilingTranscriptomeGenome-Wide Association Study

Stichwörter der Autor:innen

coronary artery diseasegenomicslinkage disequilibriumlncRNApolymorphism, single nucleotidesmooth muscle cells

Substanzen

RNA, Long NoncodingCDKN2B antisense RNA, human

Autor:innen und Institutionen

  • Department of Cell and Regenerative Biology, University of Wisconsin-Madison, Madison (E.S., C.d.M.V., R.Z., P.P., S.S., V.L.S.).
  • Department of Genome Sciences, and Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville (J.V.M., C.L.M.).

ORCID-Profile: Jose Verdezoto Mosquera, Parth Parikh, Shraddha Suryavanshi, Clint L Miller, Valentina Lo Sardo

Förderung

  • NHLBI NIH HHS
  • NIGMS NIH HHS

Zitieren

APA

Salido, E., de Medeiros Vieira, C., Mosquera, J. V., Zade, R., Parikh, P., Suryavanshi, S., Miller, C. L., & Lo Sardo, V. (2025). The 9p21.3 Coronary Artery Disease Risk Locus Drives Vascular Smooth Muscle Cells to an Osteochondrogenic State. Arteriosclerosis, Thrombosis, and Vascular Biology, 45(5), 702-721. https://doi.org/10.1161/atvbaha.124.322045

Vancouver

Salido E, de Medeiros Vieira C, Mosquera JV, Zade R, Parikh P, Suryavanshi S, et al. The 9p21.3 Coronary Artery Disease Risk Locus Drives Vascular Smooth Muscle Cells to an Osteochondrogenic State. Arteriosclerosis, Thrombosis, and Vascular Biology. 2025;45(5):702-721. doi:10.1161/atvbaha.124.322045

BibTeX
@article{Salido2025,
  author = {Salido, Elsa and de Medeiros Vieira, Carolina and Mosquera, Jose Verdezoto and Zade, Rohan and Parikh, Parth and Suryavanshi, Shraddha and Miller, Clint L and Lo Sardo, Valentina},
  title = {The 9p21.3 Coronary Artery Disease Risk Locus Drives Vascular Smooth Muscle Cells to an Osteochondrogenic State},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2025},
  volume = {45},
  number = {5},
  pages = {702--721},
  doi = {10.1161/atvbaha.124.322045}
}
Kostenlos starten →